Hepatitis C is the one of the
brothers of the hepatitis family which consists of Hepatitis A, B, C, D, E and others. Hepatitis C caused by the hepatitis C virus. It’s
called the silent nosocomial infection as patients usually don’t acknowledge
the early symptoms effects.
Symptoms of
Hepatitis C include:
·
Jaundice
·
Stomach pain
·
Loss of appetite
·
Nausea
·
Fatigue
It mimics other common Jaundice related disorders and
most commonly Hepatitis A, E.
Hepatitis C |
How do someone
Get Hepatitis C?
You get the hepatitis C virus from the blood or body fluids of an infected person.
Commonly occurs due to negligence in clinical set ups who don’t adhere to
regulations of safe blood transfusions. Body fluids transferred via sexual
contact can also cause this.
How it is circulated from one human body to another?
·
Blood transfusion by infected blood.
·
Sharing drugs and needles
·
Having sex, especially if you have an STD, an HIV infection,
several sex partners, or have rough sex.
·
Being stuck by infected needles
·
Through birth from a mother to a child
·
From Maternal transfer during pregnancy
Are There Any Long-Term Effects of Hepatitis C?
Hepatitis C |
What's the
Treatment for Hepatitis C?Liver
cirrhosis
What's the Treatment for Hepatitis C?Liver cirrhosis
The latest is a once-daily pill called
Harvoni that cures the disease in most people in 8-12 weeks. It combines two
drugs: Sovaldi (sofosbuvir) and ledipasvir.
Other options include taking a combination of
Sovaldi, Olysio (simeprevir), interferon which is taken by injection, and/or
ribavirin (which comes as a liquid, tablet, or capsule).
Side Effects of
Hepatitis C Treatment
·
Flu-like symptoms
·
Fatigue
·
Hair loss
·
Low blood counts
·
Trouble thinking
·
Nervousness
Hepatitis Treatment |
Latest Development in hepatitis C vaccination in India
Natco is the first company in India to get
approval for generic sofosbuvir tablets, 400mg, from Drugs Controller General
(India)," says the company in its filing. Sofosbuvir is a medicine used
for chronic hepatitis C infection and sold globally by Gilead Sciences, Inc,
under its brand Sovaldi. Natco will market generic sofosbuvir under its brand
HEPCINAT and through strategic partners in India. It plans to price its generic
medicine at an MRP of Rs 19,900 for a bottle of 28 tablets and expects to
launch in India very soon.
Sources and extracts from: www.webmd.com, http://www.thepharmatimes.in/
No comments:
Post a Comment